Cargando…
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience
OBJECTIVE: Data related to the safety and tolerability of treatments for pediatric type 2 diabetes are limited. The TODAY clinical trial assessed severe adverse events (SAEs) and targeted nonsevere adverse events (AEs) before and after treatment failure, which was the primary outcome (PO). RESEARCH...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661822/ https://www.ncbi.nlm.nih.gov/pubmed/23704676 http://dx.doi.org/10.2337/dc12-2390 |